New drug aims to prevent dangerous bleeding in cancer patients during treatment
Disease control
Not yet recruiting
This study tests a drug called romiplostim N01 in cancer patients whose platelet levels drop dangerously low during chemotherapy and radiation. Low platelets can cause bleeding and delay cancer treatment. The drug is compared to a standard treatment to see if it can raise platele…
Phase: NA • Sponsor: Jun wang • Aim: Disease control
Last updated May 26, 2026 12:08 UTC